FDA Flubbed Approval Of Generic Cattle Med, Judge Says

Law360, New York (April 26, 2013, 3:59 PM EDT) -- A Washington federal judge unsealed a sharply worded opinion Friday explaining her decision to suspend approval of a generic version of Bayer AG’s patented cattle medication Baytril 100, saying the U.S. Food and Drug Administration had presented an “exceptionally weak” argument for allowing a rival product.

In her April 17 opinion, U.S. District Judge Rosemary M. Collyer torched the FDA for failing to respond to a citizen petition Bayer submitted in 2006 arguing that cloned versions of antimicrobial solution Baytril approved for multiday treatments would inevitably...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.